Matches in Wikidata for { <http://www.wikidata.org/entity/Q38416059> ?p ?o ?g. }
- Q38416059 description "2015 nî lūn-bûn" @default.
- Q38416059 description "2015年の論文" @default.
- Q38416059 description "2015年論文" @default.
- Q38416059 description "2015年論文" @default.
- Q38416059 description "2015年論文" @default.
- Q38416059 description "2015年論文" @default.
- Q38416059 description "2015年論文" @default.
- Q38416059 description "2015年论文" @default.
- Q38416059 description "2015年论文" @default.
- Q38416059 description "2015年论文" @default.
- Q38416059 description "2015年论文" @default.
- Q38416059 description "2015年论文" @default.
- Q38416059 description "2015年论文" @default.
- Q38416059 description "2015년 논문" @default.
- Q38416059 description "article científic" @default.
- Q38416059 description "article scientific" @default.
- Q38416059 description "article scientifique" @default.
- Q38416059 description "articol științific" @default.
- Q38416059 description "articolo scientifico" @default.
- Q38416059 description "artigo científico" @default.
- Q38416059 description "artigo científico" @default.
- Q38416059 description "artigo científico" @default.
- Q38416059 description "artikel ilmiah" @default.
- Q38416059 description "artikull shkencor" @default.
- Q38416059 description "artikulong pang-agham" @default.
- Q38416059 description "artykuł naukowy" @default.
- Q38416059 description "artículo científico" @default.
- Q38416059 description "artículu científicu espublizáu en 2015" @default.
- Q38416059 description "bilimsel makale" @default.
- Q38416059 description "bài báo khoa học" @default.
- Q38416059 description "naučni članak" @default.
- Q38416059 description "scienca artikolo" @default.
- Q38416059 description "scientific article published on 16 February 2015" @default.
- Q38416059 description "scientific article published on 16 February 2015" @default.
- Q38416059 description "scientific article published on 16 February 2015" @default.
- Q38416059 description "teaduslik artikkel" @default.
- Q38416059 description "tieteellinen artikkeli" @default.
- Q38416059 description "tudományos cikk" @default.
- Q38416059 description "vedecký článok" @default.
- Q38416059 description "vetenskaplig artikel" @default.
- Q38416059 description "videnskabelig artikel" @default.
- Q38416059 description "vitenskapelig artikkel" @default.
- Q38416059 description "vitskapeleg artikkel" @default.
- Q38416059 description "vědecký článek" @default.
- Q38416059 description "wetenschappelijk artikel" @default.
- Q38416059 description "wissenschaftlicher Artikel" @default.
- Q38416059 description "επιστημονικό άρθρο" @default.
- Q38416059 description "мақолаи илмӣ" @default.
- Q38416059 description "наукова стаття, опублікована в лютому 2015" @default.
- Q38416059 description "научна статия" @default.
- Q38416059 description "научная статья" @default.
- Q38416059 description "научни чланак" @default.
- Q38416059 description "научни чланак" @default.
- Q38416059 description "מאמר מדעי" @default.
- Q38416059 description "مقالة علمية نشرت في 16 فبراير 2015" @default.
- Q38416059 description "বৈজ্ঞানিক নিবন্ধ" @default.
- Q38416059 description "บทความทางวิทยาศาสตร์" @default.
- Q38416059 description "სამეცნიერო სტატია" @default.
- Q38416059 name "Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie" @default.
- Q38416059 name "Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie" @default.
- Q38416059 name "Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie" @default.
- Q38416059 type Item @default.
- Q38416059 label "Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie" @default.
- Q38416059 label "Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie" @default.
- Q38416059 label "Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie" @default.
- Q38416059 prefLabel "Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie" @default.
- Q38416059 prefLabel "Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie" @default.
- Q38416059 prefLabel "Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie" @default.
- Q38416059 P1433 Q38416059-6FCA15D1-9576-4526-B323-9808394935D9 @default.
- Q38416059 P1476 Q38416059-FE309C14-DB66-40A3-8FB7-F4EB4998797E @default.
- Q38416059 P2093 Q38416059-18C3AD13-2079-4F44-9A4E-31F553566E71 @default.
- Q38416059 P2093 Q38416059-2B056491-477C-4C8E-ADF0-854717B34D36 @default.
- Q38416059 P2093 Q38416059-373EF6D7-603A-48BA-91D7-BEF31951267D @default.
- Q38416059 P2093 Q38416059-3E74D370-2DD8-4051-95B3-F1E64B29A793 @default.
- Q38416059 P2093 Q38416059-5685904F-78D1-4D29-914E-4C32916C67DD @default.
- Q38416059 P2093 Q38416059-7016216B-8864-4876-8F07-C15BE9A3E738 @default.
- Q38416059 P2093 Q38416059-7CF31A55-1C10-4DE6-8895-7712993889AC @default.
- Q38416059 P2093 Q38416059-80A2D67D-E521-4850-AB79-20294106DBF2 @default.
- Q38416059 P2093 Q38416059-8E3DADC0-2964-40E5-B2EB-2639730C02A5 @default.
- Q38416059 P2093 Q38416059-A78E529E-F1D9-42EC-9E7D-F8AA114CB701 @default.
- Q38416059 P2093 Q38416059-C7CC6151-A09C-4EA1-90C9-A6AF1FB9C9D9 @default.
- Q38416059 P2093 Q38416059-C9DF269F-F7DD-4A54-95C7-2467FA72DDA0 @default.
- Q38416059 P2093 Q38416059-D4B7916E-2F75-4CC3-B76A-B608DAFC0EAE @default.
- Q38416059 P2093 Q38416059-F436FAF4-3E16-428B-8BC6-D5591F3F030A @default.
- Q38416059 P2093 Q38416059-FBD99A52-EBB3-4755-A607-C99C1EECAA31 @default.
- Q38416059 P304 Q38416059-72051790-3736-49FA-9BA3-52170EF24FC1 @default.
- Q38416059 P31 Q38416059-2B49BD57-BD55-4356-92C0-45DEC680EE21 @default.
- Q38416059 P356 Q38416059-61C45FAF-534B-4679-91E7-775E3A41D66D @default.
- Q38416059 P407 Q38416059-C6F5C843-54DC-4C48-8579-3C586E1407DA @default.
- Q38416059 P433 Q38416059-1BBB5968-0BFF-40B4-B2B2-E87E7B017946 @default.
- Q38416059 P478 Q38416059-C7C052A6-9C22-4CD9-9E8B-64F7F11D9EF7 @default.
- Q38416059 P577 Q38416059-4A28F42C-8616-4D55-93C7-03F5440A34AB @default.
- Q38416059 P698 Q38416059-ADEA997B-811C-4FDF-9400-78E7D05C7934 @default.
- Q38416059 P921 Q38416059-7AEF2C75-7366-440D-B879-B04AAAAF3EAC @default.
- Q38416059 P921 Q38416059-FA9F6DF1-1D67-4358-AFD2-2D6177AAEDB2 @default.
- Q38416059 P356 J.EJCA.2015.01.059 @default.
- Q38416059 P698 25694417 @default.
- Q38416059 P1433 Q332260 @default.
- Q38416059 P1476 "Lapatinib versus lapatinib plus capecitabine as second-line treatment in human epidermal growth factor receptor 2-amplified metastatic gastro-oesophageal cancer: a randomised phase II trial of the Arbeitsgemeinschaft Internistische Onkologie" @default.
- Q38416059 P2093 "Andreas Eisenmenger" @default.